BioCentury
ARTICLE | Company News

University of Minnesota, Abeona Therapeutics deal

June 29, 2015 7:00 AM UTC

The university granted Abeona exclusive, worldwide rights to CRISPR- Cas9 gene editing technology and related IP to develop products for non-cancer indications, including rare blood disorders. Abeona’...